Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases

Arch Immunol Ther Exp (Warsz). 2007 Nov-Dec;55(6):373-86. doi: 10.1007/s00005-007-0042-6. Epub 2007 Dec 3.

Abstract

The CD3 zeta chain, a component of the T cell receptor (TCR)/CD3 complex, is considered to be a limiting factor in the assembly and transport of the TCR/CD3 complex to the cell surface and is crucial to receptor signaling function. Recent studies have demonstrated altered expression and function of this signal transduction molecule in T and natural killer cells in patients with chronic inflammatory/autoimmune diseases. In this review, current knowledge concerning the expression of CD3 zeta chain as well as the mechanisms responsible for abnormal expression of this molecule in systemic lupus erythematosus, rheumatoid arthritis, and childhood idiopathic nephrotic syndrome are summarized.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / genetics*
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / therapy
  • Autoimmunity
  • Child
  • Child, Preschool
  • Gene Expression Regulation* / immunology
  • Humans
  • Inflammation
  • Lupus Erythematosus, Systemic / genetics*
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / therapy
  • Models, Immunological
  • Nephrotic Syndrome / genetics*
  • Nephrotic Syndrome / immunology*
  • Nephrotic Syndrome / therapy
  • Receptor-CD3 Complex, Antigen, T-Cell* / biosynthesis
  • Receptor-CD3 Complex, Antigen, T-Cell* / genetics
  • Signal Transduction / genetics
  • Signal Transduction / immunology

Substances

  • Receptor-CD3 Complex, Antigen, T-Cell